(Total Views: 80)
Posted On: 03/29/2017 10:11:21 AM
Post# of 72441
Re: NotRichYet2 #32613
Interesting. Thanks! Seems like this would be good for blood cancers rather than tumors. In any case they are still in pre-clinical trials and not a competitor for Kevetrin. They have a long ways to go.
(0)
(0)
***On 02/26/2016 at 8:33 am Scottsmith admited to posting under 5 aliases but his post was subsequently deleted. I have a screen shot and will email it to anyone interested.
Scroll down for more posts ▼
